16 December 2010 - Deltex Medical Group plc ("Deltex Medical" "Company" or "Group"), the global leader in oesophageal Doppler monitoring ("ODM"), announces that its French distribution partner, Gamida ...

Researchers in Spain found that guiding IV fluid and vasoactive drug administration with esophageal doppler monitoring significantly reduced complications after major surgery, News Medical reports.

Multicenter randomized controlled trial results published; fewer complications translate to better patient outcomes and lower healthcare costs, as evidenced by NICE guidelines Deltex Medical, the ...

Deltex Medical Group plc (AIM: DEMG), the global leader in Oesophageal Doppler Monitoring ("ODM"), is pleased to announce the launch of its first ODM system designed specifically for veterinary use ...